Tentamen (uitwerkingen)
Lapatinib plus Capecitabine for Brain Metastases in Patients with Human Epidermal Growth Factor Receptor 2-Positive Advanced Breast Cancer: A Review of the Anatolian Society of Medical Oncology (ASMO) Experience
- Vak
- Instelling
Approximately 20–25% of all breast cancers are human epidermal growth factor receptor 2-positive (HER2+) and have historically been associated with poorer disease-free survival (DFS) and overall survival (OS) [1]. For patients with HER2+ metastatic breast cancer (MBC), the use of humanized...
[Meer zien]